Kazia Therapeutics KZIA
NASDAQ KZIA
$8.18 +0.30 (+3.81%)
At close: Oct 21, 2026 · 4:00 PM EDT

Kazia Therapeutics (KZIA) EV to EBIT (2012 - 2013)

Updated

Kazia Therapeutics' (KZIA) EV to EBIT was 576.68 for the quarter ended Dec 31, 2013.

Analysis

Kazia Therapeutics (KZIA) EV to EBIT (2012 - 2013) Analysis & Trends

Over the twelve months ended Dec 31, 2013, Kazia Therapeutics' EV to EBIT came in at 574.63; for the year ended Jun 30, 2011, it was 79.52, up 77.8% from the prior year.

  • By year, EV to EBIT came in at 44.72 in the year ended Jun 30, 2010 and 120.87 in the year ended Dec 31, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Kazia Therapeutics 606,664.05 -51.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Aug 30, 2013 1.76
Dec 31, 2012 0.45
API Access

Kazia Therapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=KZIA&period=max&api_key=YOUR_API_KEY